Analysis of 174 bladder tumors revealed HER2 expression in 159 specimens (91.38%), distributed as 36 with a 1+ score (20.69%), 106 with a 2+ score (60.92%), and 17 with a 3+ score (9.77%). This evidence concerns the gene ERBB2 and urinary bladder neoplasm.